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1. Introduction  
The use of bone transplants in orthopaedic procedures has become crucial to treat a great 
number of bone diseases including bone tumour operations, knee or total hip revision 
arthroplasty and even beyond the orthopaedic scope such as in craniomaxillofacial surgery. 
Approximately 10% to 15% of the orthopaedic procedures carried out every year in the 
U.S.A. employ some kind of musculoskeletal transplant. Annually, about 650 thousand 
bone-based grafts are distributed by the American Tissue Banks, which clearly shows the 
importance of processing, controlling and storage of this type of material. 
As opposed to other organs such as heart, liver or kidneys and most of the soft tissues, the 
bone can be processed by many ways, can be stored longer and has been implanted till 
recently without prior testing compatibility. Moreover, the grafts can be obtained from 
oneself, living or cadaver donors, or derived from other species or even from non organic 
biomaterials. However, the offer for grafts is far behind the demand. Despite the success rate 
of about 85% with the use of bone grafts in orthopaedic surgery, patient waiting list for 
these grafts keep growing day by day either in the public or private health service. 
The homologous deep-frozen grafts have been frequently used, although availability is very 
limited and a certain risk of transmitting contagious diseases cannot be thoroughly ruled 
out. On the other hand, though homologous freeze-dried grafts have virtually eliminated 
the risk of transmissible diseases is still lacking availability and therefore, alternative 
biomaterials from synthetic or natural source have been considered and carefully studied. 
Among them, the use of freeze-dried grafts from bovine sources is a suitable alternative 
with many advantages over autologous or homologous deep-frozen ones due to their great 
physicochemical and structural resemblance to human bone and their practically endless 
availability. As a non specific xenograft however, it may possibly present adverse 
immunological and inflammatory reactions. Nevertheless, our physicochemical processing 
protocols have been developed in order to significantly minimise these problems, 
decreasing antigenicity and thus, turning the bovine freeze-dried bone an important 
biomaterial for large use in reconstructive surgery. 
Up to date, it is necessary, an increased knowledge about some kinds of available grafts 
including biological and mechanical aspects, sources and a careful analysis of outcomes, 
since transplant of grafts in general is responsible for a remarkable improvement in people’s 
quality of life and their social reinsertion. Moreover, bone implants are far from being a 
www.intechopen.com
 Recent Advances in Arthroplasty 
 
236 
novel issue and it is crucial that already in the XXI century, we have to know the reasons for 
its use and, over all matters, to clearly determine our results.  
This chapter is intended to present a brief review of the history of bone grafts, indications 
for use, storage details and differences of processing techniques as well as to present the 
experience of our department with the use of freeze-dried bone from bovine origin in a 
thousand orthopaedic procedures. 
2. History 
The idea of transplanting tissues between individuals of the human species and even 
between individuals of distinct species is very ancient, dating to the early Christian era. 
Empirically, Cosmas and Damian, in the second century, were regarded as the pioneers of 
bone transplantation by having removed a leg of an individual due to an advanced tumour 
and soon deployed a new leg taken from a freshly killed Moro. However, it was Sir William 
MacEwan in 1880 who successfully reconstructed the humerus of a boy with the tibia 
obtained from another child. On the other hand, the first transplant between different 
species was conducted by the Dutch surgeon Job van Meekren in 1668. According to 
Godwin, he successfully transplanted part of the skull of a dog in a traumatic defect of the 
skull of a soldier. Deeply concerned of being excommunicated by the church for having 
undergone a non-Christian method of treatment, the soldier asked the surgeon to remove 
the graft, but due to time elapsed, this could not be completely removed since it was already 
fully integrated. 
Is not well known when the first studies on bone grafts started. However, Ollier and Barth 
in the late 19th century, were the first to intensively investigate and report the biological 
properties of the tissue and concluded, though partially correct, that bone and periosteum 
remain viable when transplanted, contributing to new bone formation. 
Assuming that the cells survive in the graft, even when removed from the donor, Albee in 
1915, concluded in a classical work, the most suitable tissues for transplant are those 
originated from the connective tissue such as bone, fat and fascia. Ten years later, in 1925, 
Lexer published his experience with transplants and total joint replacement called 
"arthroplasty" to all surgical procedures performed in an attempt to restore joint movement. 
3. Terminology 
It is important to know the terminology frequently used when dealing with this kind of 
procedure in relation to (a) different types of graft; (b) distinction between grafts and 
transplants; (c) the process of new bone formation, and; (d) the use of consolidation and 
osteointegration, since these terms vary greatly in the literature and an attempt to 
standardized them has not been effective. The nomenclature most commonly used is as 
follows: 
3.1 Types of grafts 
Grafts received from oneself and reimplanted in oneself should be called autogenic, 
autogenous, autologous or autograft. The graft obtained from other individuals, but 
intended to a host of the same species, should be called allogeneic, allogenous, homologous, 
allograft or homograft, while grafts from donors to hosts of different species should be 
called xenogenic, xenogenous, xenologous, xenografts or interspecific. 
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a. Grafting and transplantation 
A Brazilian Board Resolution on Biomaterials - BBRB No. 220 of December 27th, 2006 
considers the term transplantation to describe the placement of bone graft during a surgical 
procedure, so the graft is the product and the use of this tissue is called a transplant. 
b. Bone formation and osteointegration 
In the process of bone formation and the biological events responsible for osteointegration 
the following terms are used: osteogenesis when bone growth is derived from osteoblasts 
transferred along with the graft; osteoinduction when the newly formed bone derives from 
the recruitment of mesenchymal cell receptors that differentiate into osteoblasts; 
osteoconduction when the ability of a material (usually inorganic) allows the new bone 
tissue from pre-existing bone, requiring the presence of osteoprogenitor (preosteoblast) cells 
or bone tissue. 
c. consolidation and osteointegration 
On the biological process occurring after transplantation it should be clear that the graft can 
consolidate and/or embedded (incorporate) into the host bone. Therefore, consolidation and 
incorporation processes are distinct and should be well understood respectively, as the 
union that occurs between the graft and host bone or reabsorption and cell recolonisation 
between graft and host bone resulting in a progressive replacement of one by another. Thus, 
the imaging methods for assessment of these features can only provide an idea of the 
evolution of this process, but precise assessment on the consolidation and incorporation can 
be only determined by histopathology. 
4. Biological characteristics 
Bone tissue basically consists of an organic matrix of collagen type I, containing low 
molecular weight proteoglycans and non-collagen proteins, a mineral part (mainly 
hydroxyapatite) and water, corresponding to 25%, 65% and 10% of the bone weight, 
respectively. 
Despite the great power for repair, the bone does not always respond appropriately when 
affected by extensive osteolysis. Because of these situations, extremely frequent in 
orthopaedic surgery, especially in RTHAs, there is eagerness to search for high quality bone 
grafts and other biomaterials that can fill these gaps and restore availabilty. 
Bone grafts can be of cortical, cancellous or cortico-cancellous types, depending on the site 
of origin and can be used in blocks, segments or morselised. These different types of bone 
grafts will provide distinct mechanical and biological responses. For instance, the cortical 
bone is less osteogenic than the spongy bone; showing however, a higher structural quality, 
for long periods and even in the absence of adequate integration. The greater osteogenic 
features of cancellous bone (Figures 1a, 1b and 1c) has been recognised for more than 40 
years, which has stimulated its use in many situations, being crucial for use in RTHAs. 
After the transplant of a spongy bone there is a sequence of histological events that starts 
with inflammatory response, macrophage invasion, neovascularization and differentiation 
of mesenchymal cells into osteoblasts that places an osteoid layer in a necrotic trabecular 
bone remainings. Viable nuclei are reabsorbed by osteoblasts and the matrix is eventually 
replaced by necrotic trabeculae of newly formed bone. All these events are probably 
mediated by inducing protein factors. 
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Fig. 1a. Revision as of right femoral component with bone graft and frozen morcelised 
impacted. 70 months of evolution. 
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Fig. 1b. Revision of femoral component left with bone graft and bovine freeze-dried, 
morcelised impacted. 60 months of evolution. 
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Fig. 1c. Revision of the acetabular component with lyophilized bovine bone graft and graft 
block frozen morcelised impacted. 82 months of evolution. 
Histologic assessment was performed and described by Buma et al. in eight patients who 
underwent revision of the acetabular component after previous operation with impacted 
bone grafting technique. All but one, that has not even shown revascularization, samples 
revealed different stages of integration depending on the time elapsed following 
implantation. At 4 months, there was an established revascularization, osteoblasts 
replacing parts of the implant and presence of a small graft and new bone formation. 
Samples with a longer evolution showed the graft replaced with new bone. Another 
sample with 28 months in contact with the cement layer revealed viable bone presenting, 
however, a predominantly fibrous tissue interface5. Similar results on the femoral 
component were demonstrated in another study published by Ullmark and Obrant in 
2002 and by Galia in acetabular biopsies in patients with traumatic dislocation of RTHA 
(Figures 2a and 2b) 3 years after the first revision procedure. 
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Fig. 2a. Biopsy bone grafting with bovinefreeze-dried three years after surgery. White arrow 
= graft; black arrow = new bone 
In a classic study, Urist described ectopic bone formation after intramuscular 
implantation of demineralised bovine bone matrix in rabbits and rats. This discovery was 
crucial in the biomaterial and graft fields and supported the search for substances capable 
of inducing cell differentiation present in bone matrix. Subsequent investigations, led by 
Urist demonstrated that low molecular weight proteins could be extracted from 
demineralised bone matrix, having great osteogenic activity and being called bone 
morphogenetic proteins (BMPs), and belonging to a superfamily of proteins called 
transforming growth factors beta (TGF-ß) responsible for inducing growth. The 
superfamily of TGF-ß proteins regulates many biological processes including cell growth, 
differentiation and embryo formation. BMPs have been shown to be important regulators 
in the development and regeneration of skeletal tissue having the BMP2 and BMP7 the 
highest osteoinductive potential. Another important factor is the reaction triggered by 
antigenic grafts. The antigens present into the graft cells probably play a very important 
role on the outcomes of bone transplants. It seems clear that these reactions are not 
mediated by T or B lymphocytes, but by other cells in the bone marrow. In vitro evidences 
suggest that the granulocyte lineages in the bone marrow are responsible for triggering 
immune responses and removal of bone marrow cells therefore and can be directly related 
to a decrease in graft immune response. 
Fresh, frozen and lyophilized bone grafts were experimentally compared in rabbits from the 
immunological point of view. The first two grafts caused serologically detectable immune 
response, while the third one, highly purified (free of fat and marrow cells) was not able to 
immunologically sensitize animals. 
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Fig. 2b. Biopsy of frozen human bone graft. 36 months of evolution. White arrow = graft; 
black arrow = new bone. 
Although the freeze-dried grafts, whether human or bovine, are available in many medical 
centres worldwide, most work on RTHAs refers to the use of frozen bone grafts in blocks or 
cortical, but especially, most recently the spongy morcelised and impacted. 
Tagil, in his PhD thesis published in 2000, attempted to explain the reasons for succeeding 
using the technique of frozen morcelised and impacted bone, once theoretically, the large 
volume of necrotic bone exposed to great mechanical stress tend to collapse, as in the 
vascular necrosis of the femoral head or knee. After detailed study, Tagil found out the 
following possibilities: (a) morcelised bone, as in a comminuted fracture, would produce 
extensive surface contact allowing access and release of biologically active substances; (b) 
impaction may improve osteoconductive properties of the graft leading to the release of 
BMPs and this way favouring osteointegration and; (c) the high elasticity may allow small 
deformations that would stimulate new bone formation. The importance of this study lays 
in the fact that it is essential, from a scientific standpoint, to know the pros and cons of a due 
technique and why results may be good or bad, to better use and indicate such a procedure 
more securely and confidentially.  
5. Mechanical characteristics 
In addition to the biological characteristics, the mechanical aspects are very relevant and can 
be decisive in the choice and obtained results using a due graft. Itoman and Nakamura, in 
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1991, studied the histological and biomechanical properties of different ways of bone graft 
processing in rats and noted that an increased stiffness of the bone after freezing at -80°C 
and lyophilising it. The freeze-dried demineralised bone has initially decreased its 
mechanical strength. However, after 16 weeks, a progressive increase in resistance of the 
grafts was observed and was likely related to its biological interaction, which might be an 
indicator of the osteoinductive properties of the graft. They also concluded that on the 
features of integration, as expected, the autologous bone showed the best results. 
The physical properties of human and bovine trabecular bone are documented and their 
results are available, however, the range of dispersion is very wide. The Young's module, 
for example, in one study ranged from 70 to 673 MPa and compressive strength varied 
between 2.44 and 6.24 MPa. This dispersion occurred for both human and bovine bone and 
may be related to several factors such as donor age, bone density and methodology used in 
the study. 
Cornu et al. in 2001, has demonstrated in vitro that the lyophilised morcelised and impacted 
bone is mechanically superior to the morcelised and impacted deep-frozen bone since, at 
least, has the same resistance after impaction, that is achieved however, more quickly and 
with fewer impacts, and the authors assumed as to the fact that lyophilised material was 
devoid of fat and bone marrow. Moreover, Macedo et al. in 1999, using an automated 
compression machine compared in vitro, the compressive strength of frozen and freeze-
dried bovine bone rehydrated for an hour and found out that deep-frozen bovine bone 
grafts after defrosting, has similar compressive loads and deformation rate of the rehydrated 
lyophilised bovine bone. 
6. Methods sterilization, infectious diseases and biosafety 
Another extremely important issue is the study of methods of sterilization of frozen and 
freeze-dried grafts, since there still remains controversy and need for further studies. The 
currently available techniques have advantages and disadvantages regarding efficacy and 
maintenance of mechanical and biological properties. Significant deleterious effects on the 
use of cobalt 60 in the sterilisation of freeze-dried grafts have been reported, demonstrating 
that, even at low dosage, radiation is capable of destroying the morphogenetic properties, 
mainly in non-demineralised bone. 
The effects of radiation on the biomechanics of the grafts are dose-dependent. Fidele et al. in 
1995, studied the damage caused by the application of different doses of gamma radiation 
exposure on seven biomechanical parameters of frozen allogenic patellar bone-grafting. The 
sterilization dose accepted for inactivation of HIV, for example, is about 25 kGy. However, 
four out of the seven parameters measured were reduced after 20 kGy and after 30 kGy all 
parameters have shown significant reductions. Also, Zhang, Cornu and Delloye in 1997, in 
an experimental study in rats, compared the ability of graft osteoinduction after gamma 
radiation sterilisation (25 kGy), ethylene oxide (EO) at 55°C and 40°C or preservation in 
ethanol showing that the OE at 40°C and ethanol have not negatively affected the 
osteoinductive capacity, gamma radiation has decreased 40% and OE to 55°C had an almost 
completely loss of this potential. Some authors indicated that other factors in sterilisation 
need to be observed are the toxic residues from the OE that may remain in the graft and are 
released when in contact with liquids. Reference is also considered to the toxicity of gamma 
radiation when in contact with fat present in the graft, in addition to the mechanical change 
that the radiation may cause. 
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Another way to sterilise is to autoclave the bone, although it has also limitations. According 
to the recommendation of the European Community, aimed at inactivating prions 
(infectious proteins), tissues from bovine origin should be sterilised in an autoclave at 132°C 
for 1h, but the biomechanical effects of this method of sterilisation has proven to reduce in 
approximately 70%the mechanical resistance to compression of the graft. Moreover, many 
authors support the safety of non-sterilised bone grafts provided by banks that adopt 
appropriate methodology for donor selection and quality control and such control is so 
important that when applying these criteria, 20% to 30% of the harvested material will be 
discarded due to bacteriological or serological inadequate results. Despite this severe 
control, to name a few, in November 2001 there were two reported cases in the U.S., by 
Clostridium sordellii infection in surgical patients who received bone transplants. In March 
2002, the Centre for Disease Control and Prevention (CDC, Atlanta) has received 26 reports 
from different locations of secondary bacterial infections in transplanted musculoskeletal 
tissues. In these events the CDC investigated donors and confirmed the presence of those 
bacteria in their tissues. Several other notifications have been done and are reported every 
year, which provides the need for even a more strict control, revision of adopted routines 
and, perhaps, searching for methods of sterilisation that may minimally interfere with 
quality of the graft. 
Taylor in 2002, stated that prions, responsible for Creutzfeldt-Jakob disease in humans and 
bovine spongiform encephalitis, unlike bacteria and viruses, are resistant to procedures such 
as autoclaving or exposure to sodium hydroxide, but, the association of alkaline substances 
and heat even at 100°C for 1 minute  appears to be effective to  inactivate prions. In addition, 
when isolated used, sodium hypochlorite also demonstrated ability to deactivate prions. 
Alike prions, potentially transmissible viral diseases such as hepatitis A, B or C, HIV and 
HTLV, and other more recently isolated viruses and certain types of tumour cells, should 
also be of concern, even with current knowledge and care from the point of view of 
serological or other diagnostic methods, which clearly demonstrates the importance of a 
wide discussion about sterilisation processes. 
As published by Sugihara et al. in 1999, about 1% of tumour cells in 137 femoral heads 
subjected to histological examination in patients undergoing THA due to primary arthrosis 
and Palmer et al. also found high rates of histological abnormalities in 1146 patients with hip 
joint arthrosis, even suggesting that pathological examinations should be included as part of 
screening for donor tissues. 
7. Processing and storage 
Many ways of processing and storage bone tissue for clinical application have been 
proposed and used in Tissue Banks around the world. Among them, we highlight the deep-
frozen (-80oC) and lyophilisation, which are the most widely used and accepted methods. 
The ultralow freezing temperature is reached in freezers that go as low as -80oC with 
graphical systems constantly monitoring the temperature, having their own power 
generators and emergency alarms alerting when temperature increases. So, after rigorous 
screening of donors (living or dead), culture and serological tests for bacteria and fungi, and 
processing in a surgical environment the graft is subjected to freezing at-80C that allows its 
storage for up to 5 years. However, it is worth of note that low temperatures do not play any 
role in the sterilisation of the material, but decreases antigenicity indeed, allowing more 
useful handling of the graft. 
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Lyophilisation, as proposed and spread in 1951 by the USA Navy Tissue Bank24, is a 
technique by which dehydration of the water contained in a product is removed by 
sublimation, i.e., starting from a previously frozen material, placed under vacuum, the 
water goes directly from a solid state into mist30. Before that, however, the bone graft is 
washed, centrifuged, decellularised, chemically degreased and subjected to physical 
processes of cleaning and sterilisation preserving only the protein-mineral matrix, thus 
decreasing antigenicity23 (Figure 3). 
 
 
Fig. 3. Histological section of bone sample degreased, decellularized and freeze-dried. Note 
that the only remaining protein-mineral matrix. 
Moreover, lyophilisation is a method of processing and storage of musculoskeletal tissues 
that allows not only the use of human bones, tendons and fascias (allogeneic), but also and 
mainly the bovine (xenogenic) ones, since by reducing antigenicity, provides 
biocompatibility, sterilisation and can be stored at room temperature. 
Currently, in major health centres different types of bone grafts are available for 
reconstructive orthopaedic surgery: frozen and freeze-dried autologous,  allogeneic and 
lyophilised xenogenic (bovine). The autologous graft, though not requiring processing, has 
been considered from the integration viewpoint, the preferred tissue for bone replacement. 
There is evidence that survival of osteoblasts and osteocytes from autologous graft are 
dependent on the quality of the receptor bed. Moreover, the amount of graft obtained is 
limited, surgical time is increased and complications, either systemic or local, of the 
intervention required to obtain the graft ranges from 21% to 49%. 
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The frozen allogeneic graft is the most widely used and accepted nowadays, but due to the 
reduced number of Tissue Banks in our country and the small number of donations is not 
always available to a wider use. Moreover, despite of all care and biosafety standards 
adopted by the banks there is still some risk of transmission of infectious diseases and 
tumours. 
The lyophilised allogeneic graft,  produced by the majority of U.S. tissue banks, is still not 
widespread among us, and few studies have reported the use of this graft in orthopaedic 
surgery and with a small number of cases and limited methods for assessing 
osteointegration, further studies are needed to better define its use  (Figures 4a and 4b). 
 
 
 
 
Fig. 4a. Sample of lyophilized bovine graft. 
The xenogenic grafts, commonly used in dentistry, although controversial, are beginning to 
be used in  orthopaedic surgeries, especially those of bovine origin, due to its easy 
preparation, availability and similarity. The bovine bone has chemical composition, 
porosity, size, shape and biological behaviour similar to its human counterpart as it can be 
clearly observed in Table 1. Besides those features, bovine graft provides structural support, 
osteoconduction and a high content of calcium and phosphorus, all of them essential factors 
for the newly formed bone tissue. 
The most important issue, regardless of the type of graft chosen by the surgeon, is the 
guarantee that the graft has been processed and stored according to the standards of graft 
management as established by the Associations of Tissue Banks and the national and 
international health authorities. 
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Fig. 4b. Sample graft ½ lyophilized human femoral head. 
 
Readings Human (%) CI* 95% Bovine (%) CI* 95% 
Water 7.93 - 7.75 - 
Fat 0.06 0.1 0.1 0.1 
Nitrogen 4.3 0.1 4.3 0.1 
Proteins 27.5 0.2 27.2 0.2 
Phosphorus 11.9 0.1 11.9 0.2 
Total P2O5   27.1 0.2 27.2 0.7 
Calcium  24.6 0.7 23.7 0.6 
Ca/P 2.06 - 1.99 - 
Total sodium  0.57 0.01 0.46 0.01 
Ashes 64.8 0.6 64.3 0.1 
Chlorides  1.3 0.06 1.3 0.2 
*CI, Confidence Interval 
Table 1. Physical and Chemical analysis of lyophilised bones HCPATB 
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8. Musculoskeletal tissue banks  
Like in the USA, where the American Association of Tissue Banks (AATB) regulates and 
supervises the functioning of all in-country tissue banks since 1976, in Brazil the Ministry of 
Health, with the Norm No. 220 of December 27th, 2006, provides the technical regulations 
for the functioning of Musculoskeletal and Skin Tissue Banks of human origin. This 
regulation relates to the facility characteristics, screening of living donors or cadavers, 
equipment and human resources. These rules, although quite rigid, greatly increased the 
quality of processed tissues and the safety on its use. 
In relation to screening, the decision to accept or reject a donor is carried out by the Medical 
Director of the Bank of Musculoskeletal Tissues (BMST) after rigorous tests and following a 
established protocol. As the protocols used by the Tissue Banks, one must consider the 
history, physical examination and laboratory tests of the donor. 
 
Name: Medical record No.: 
Date of Birth:  Age (y): Sex: Race: 
Checking date: Collecting date: 
DONOR PAST HISTORY  
 CONDITIONS YES NO 
 Toxic substances or illegal drug abuses   
 HAS THE DONOR HAD ANY BEHAVIOUR OR 
OTHER CONDITION BELOW IN THE PAST  
12 MONTHS? 
  
- Professional sex, illegal drugs or has any related person with this 
done so? 
  
- Multiple sexual partners?   
- Homosexual intercourse or sex with homosexual related 
persons? 
  
- Any unprotected sexual intercourse with known HIV,  
hepatitis B, C or other blood transmitted infection 
person? 
  
- Arrested or has been in a prison?    
- Submitted to acupuncture, tattooing, and permanent makeup or 
piercing? 
  
- A blood transfused or hemodialysed sexual partner?    
- Any malignant disease?    
- AIDS/HIV infection?   
- Any autoimmune disease?   
- Any neurological, degenerative or impairing disease?    
- Chronic kidney failure?   
- Past or active tuberculosis?   
- Sexually transmitted diseases?   
- Any osteometabolic diseases?   
- Any skin burns?   
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- Malaria or lived in an endemic area for malaria in the past 36  
months? 
  
- Creutzfeldt Jakob disease?   
- Any undiagnosed situation or infection?   
- Any human derived pituitary growth hormone treatment?     
- Any duramater or corneal transplant?    
- Chemotherapy or radiation therapy?   
- Any orthopaedic surgery in the donor site?    
- Any surgical procedure due to undefined situation?   
- Any biopsy or suspicion of muscoskeletal tumour?   
- Any non-obstructing jaundice or jaundice in any related person?   
- Death by an unknown cause?    
- Chronic use of steroids?   
- Any diagnosed bacterial or fungal infection while in hospital?    
- Vaccines:   
- Unfit for 24h: toxoids or vaccines (diphteria, tetanus, cholera, 
typhus, paratyphus, influenza, pertussis, poliomyelitis Salk and 
serum non-derived B hepatitis) 
  
- Unfit for 2 weeks: animal or virus attenuated vaccines (measles, 
parathyroid, yellow fever and Sabin poliomyelitis)  
  
- Unfit for 1 month: rubeolla   
- Unfit for 1 year: experimental vaccines, hepatitis B 
hyperimmune globulin, rabbis vaccine (prior animal bites), 
passive immunizations  
  
 CONDITIONS YES NO 
- Any blood or blood product transfusion?   
- Received any crystalloid solution resulting in hemodilution over 
50% of the intravascular volume in the past 2h prior to blood 
sample analysis? 
  
- Received any synthetic colloid solution resulting in 
hemodilution over 50% of the intravascular volume  
in the past 48h prior to blood sample  
analysis?   
  
- Past history of accident or exposure to suspected or confirmed 
contaminated blood by HIV, hepatitis B or C? 
  
- Hemophiliacs receiving blood or blood products from newly 
sexual partners within the past 12 months? 
  
- Chronic hemodialysis?   
- Mechanical ventilation over 72h?    
 AGE  LIMITS FOR DONORS 
a. bone tissue:                                 below 18 and over 70 years 
b. tendon tissue:                              below 18 and over 55 years 
c. osteochondral tissue:                  below 18 and over 45 years 
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 PHYSICAL EXAMINATION (CONDITIONS) YES NO 
- Skin appearance of sexuallly transmitted or malignant  
diseases? 
  
- Tattoos, signs of piercing or definitive makeup?   
- Scars prior to the harvesting procedure?   
- Perineal or perianal skin appearance of sexually transmitted 
disease? 
  
- Needle punctures suggestive of intravenous drug abuse?   
- Jaundice?   
- Hepatomegaly?    
- Diffuse lymph node swelling/   
- Kaposi Sarcoma?   
 LAB PROFILE 
 EXAM  RESULTADO   EXAME RESULTADO 
 Hb/Ht     WBC  
 ESR     Glucose  
 Bilirubins     Alcaline 
Phosphatase 
 
 GOT     GPT  
 Coagulation     Platelets  
 Urine 
analysis 
    Urine culture  
 HbsAG     Anti-HBc  
 Anti-HCV     Anti-HIV 
1+2 
 
 HTLV1/HTL
V2 
    Toxoplasmos
is IgM/IgG 
 
 Chagas     Epstein-Barr 
virus 
 
 CMV 
IgM/IgG 
    HBV-PCR  
 HCV-PCR     Lues PPR 
test 
 
 HIV-PCR       
 RADIOGRAPHIC EXAM 
Results: ........................................................................................................................................... 
................................................................................................................................................................ 
Source: Bank of musculoskeletal tissues (BMST), Hospital São Vicente de Paulo - Passo Fundo  
BMST of the Hospital de Clinicas de Porto Alegre University Hospital (licensed, but awaiting 
accreditation by Ministry of Healthy Quality Control Committee - ANVISA) 
 
Table 2. Screening protocol for muscoskeletal tissue donors.   
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9. Conclusion 
There are many differences when comparing the types of graft, with variations as for the 
source, production methods, processing, uses (block or shredded) sterilisation, storage and 
cost of the process. Thus, it is essential the implementation of protocols for processing and 
quality control of all types of bone grafts. This measure will facilitate the monitoring and 
analysis of the results obtained in distinct surgical procedures, and shall provide grafting 
material of better quality, thoroughly tested and ready available. 
Although there are reports of the use of bone grafts and transplants for many years, many 
mechanical and biological issues such as physical and chemical composition, incorporation, 
bone remodelling and immune responses are still incompletely assessed. These issues are 
still requiring more knowledge and further clinical and laboratory investigations to allow a 
more scientifically based choice of the graft and appropriate indication to surgical use on 
any particular situation. 
There is no doubt on the importance of bone transplants in orthopaedic surgery, especially 
in hip procedures. Their results are well-known and, to some extent predictable when its use 
is carried out by experienced surgeons. It is also indubitable that bone tissue is a biologically 
privileged material, since several alternative bone grafts can be used quite well. It is 
undeniable, however, that we still knowing little about many aspects of the host-graft 
interaction and sometimes seems we are resigned with this situation, when in fact, many 
studies have yet to be carried out in several ways to attempt to answer questions that 
sometimes are underestimated, since "most of the time the graft works". For instance, why 
do 85% of the grafts theoretically integrate? Though it seems a good percentage, how about 
the other “not so lucky” 15% of the cases? Is it a matter of technique, immune response, 
mechanical effect or biological feature? Which is the best substitute for autologous grafts? 
The frozen allogeneic sterile or non-sterile or the freeze-dried irradiated or autoclaved graft? 
Should a method of definitive sterilisation be employed by the Tissue Banks? 
These are just some of important yet unanswered issues that should be carefully 
investigated and analysed if best clinical responses, increased biosafety and lower 
complication rates as well as higher scientific basis to precisely and reliably analyse the 
grafts and surgical outcomes are to be sought. 
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